alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

EXHIBIT 15.1 LETTER RE: UNAUDITED INTERIM FINANCIAL INFORMATION

Board of Directors and Shareholders
STERIS Corporation

We are aware of the incorporation by reference in the following Registration
Statements and related Prospectuses of our report dated October 19, 2000,
relating to the unaudited consolidated interim financial statements of STERIS
Corporation and Subsidiaries that are included in its Form 10-Q for the quarter
ended September 30, 2000:

<TABLE>
<CAPTION>

  Registration
      Number                                        Description                                         Filing Date
--------------------    ----------------------------------------------------------------------    --------------------------
<C>                     <S>                                                                       <S>
333-40082               Form S-8 Registration Statement -- Nonqualified Stock Option              June 26, 2000
                        Agreement between STERIS Corporation and Laurie Brlas and the
                        Nonqualified Stock Option Agreement between STERIS Corporation and
                        David L. Crandall

333-40058               Form S-8 Registration Statement -- Nonqualified Stock Option              June 23, 2000
                        Agreement between STERIS Corporation and Les C. Vinney

333-65155               Form S-8 Registration Statement -- STERIS Corporation Long Term           October 1, 1998
                        Incentive Stock Plan

333-55839               Form S-8 Registration Statement -- Nonqualified Stock Option              June 2, 1998
                        Agreement between STERIS Corporation and John Masefield and the
                        Nonqualified Stock Option Agreement between STERIS Corporation and
                        Thomas J. DeAngelo

333-32005               Form S-8 Registration Statement -- STERIS Corporation 1997 Stock          July 24, 1997
                        Option Plan

333-06529               Form S-3 Registration Statement -- STERIS Corporation                     June 21, 1996

333-01610               Post-effective Amendment to Form S-4 on Form S-8 -- STERIS                May 16, 1996
                        Corporation

33-91444                Form S-8 Registration Statement -- STERIS Corporation 1994 Equity         April 24, 1995
                        Compensation Plan

33-91442                Form S-8 Registration Statement -- STERIS Corporation 1994                April 24, 1995
                        Nonemployee Directors Equity Compensation Plan

33-55976                Form S-8 Registration Statement -- STERIS Corporation 401(k)Plan          December 21, 1992

33-55258                Form S-8 Registration Statement -- STERIS Corporation Amended and         December 4, 1992
                        Restated Non-Qualified Stock Option Plan
</TABLE>
                                                       /s/     Ernst & Young LLP

Cleveland, Ohio
November 3, 2000
Exhibit 99.2


     CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


        In connection with the filing of the Quarterly Report on Form 10-QSB for
the Quarter Ended March 31, 2003 (the "Report"), by GVC Venture Corp. (the
"Registrant"), the undersigned hereby certifies that, to the best of his
knowledge:

1.   The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934, as amended, as applicable; and
2.   The information  contained in the Report fairly  presents,  in all material
     respects,  the  financial  condition  and  results  of  operations  of  the
     Registrant.




                                         /s/ Marc Hanover
                                         ---------------------------------------
                                         Marc Hanover
                                         Vice President, Finance and Treasurer
                                         (Principal Financial Officer and
                                         Principal Accounting Officer)

                                         May 15, 2003

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN
PROVIDED TO GVC VENTURE CORP. AND WILL BE RETAINED BY GVC VENTURE CORP., AND
FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.
(logo)**Prudential**

**PrudentialAsset Resources**

PGIMReal Estate Finance

2100Ross Avenue, Suite 2500, Dallas TX 75201

Tel214-777-4500

 

Abusiness of Prudential Financial, Inc.

 

WellsFargo Bank, National Association

CommercialMortgage Servicing

MACD1086

550South Tryon Street, 14th Floor

Charlotte,North Carolina 28202

Attention:Asset Manager

 

 

RE:         **WFCM 2015-SG1**

Period: **January 1, 2018 to December 31,2018(the "Reporting Period")**

 

 

**Annual ComplianceStatement**

 

I, Joni Brown-Haas, in my capacity asPresident and Managing Director of Prudential Asset Resources, Inc. (the"Company") hereby certify with regard to the Company's role asSub-Servicer under the Sub-Servicing Agreement, (the "Agreement")dated as of August 1, 2015, pertaining to the above-referenced certificates,that:

 

       (i)           areview of the activities of the Company under the Agreement  during theperiod noted above, and  of the performance of the Company under theAgreement during the  relevant  period  has been made under mysupervision, and

 

     (ii)           to thebest of my knowledge, based on such review, the Company has fulfilled all itsobligations under the Agreement throughout the relevant period, and

 

   (iii)           to thebest of my knowledge, based on such review, the Company has fulfilled itsobligations under its sub-servicing agreement in all material respects, and

 

    (iv)           theCompany has maintained an effective internal control system over the servicingof mortgage loans including the Loans serviced by the Company, and

 

     (v)           theCompany has not received any notice regarding qualification or challenging thestatus of the Lower Tier REMIC or the Upper Tier REMIC as a REMIC, from the IRSor any other governmental agency or body.

 

Effectiveas of February 22, 2019

 

 

/s/Joni Brown-Haas

JoniBrown-Haas

Presidentand Managing Director

PrudentialAsset Resources, Inc.
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

June 7, 2006 Clifford W. Taylor, Chief Justice
130326 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 130326 COA: 257149 Wayne CC: 04-001652-01 GREGORY RAY WASHINGTON, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the November 22, 2005 judgment of the Court of Appeals is cons idered, and it is DENIED, because we are not persuaded that the questions presented s hould be reviewed by this Court.

K ELLY , J., would grant leave to appeal.

t0531 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

June 7, 2006

Clerk
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Wage Chronology: Lockheed-California Company, Div. of Lockheed Aircraft Corp., and Machinists' Union

              																	United States. Bureau of Labor Statistics. 						*Wage Chronology: Lockheed-California Company, Div. of Lockheed Aircraft Corp., and Machinists' Union : Bulletin of the United States Bureau of Labor Statistics, No. 1904*,												Washington, D.C: 								U.S. Dept. of Labor, Bureau of Labor Statistics; for sale by the Supt. of Docs., U.S. Govt. Print. Off., 										1977,									https://fraser.stlouisfed.org/title/4890,			accessed on September 11, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5425 *Alpha*-2-glycoproteins immunological test system. ( a ) *Identification.* An *alpha*-2-glycoproteins immunolgical test system is a device that consists of the reagents used to measure by immunochemical techniques the *alpha*-2-glycoproteins (a group of plasma proteins found in the *alpha-*2 group when subjected to electrophoresis) in serum and other body fluids. Measurement of *alpha*-2-glycoproteins aids in the diagnosis of some cancers and genetically inherited deficiencies of these plasma proteins.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 65 FR 2312, Jan. 14, 2000]
#### Joseph Page et al. *v.*Zoning Board of Appeals of the Town of Southington et al.

The motion by the defendant Joseph Bepczynski et al. to set aside the judgment of the trial court in the appeal from the Court of Common Pleas in Hartford County is denied.

*606
      *John V. Zisk,*for the appellants (defendant Repczynski et al.).

*Gerald C. Mitchell,*for the appellant (named defendant).

*James M. 8. TJllman,*for the appellees (plaintiffs).

Argued October 9

decided October 9, 1968
# C_2015034EN.01000601.xml

| 2.2.2015 | EN | Official Journal of the European Union | C 34/6 |
| --- | --- | --- | --- |

2.2.2015

EN

Official Journal of the European Union

C 34/6

---

Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 6 November 2014 — Freistaat Bayern v Verlag Esterbauer GmbH

(Case C-490/14)

(2015/C 034/05)

Language of the case: German

Referring court

Referring court

Bundesgerichtshof

Parties to the main proceedings

Parties to the main proceedings

Applicant: Freistaat Bayern

Applicant:

Defendant: Verlag Esterbauer GmbH

Defendant:

Question referred

Question referred

In relation to the question whether a collection of independent materials exists within the meaning of Article 1(2) of Directive 96/9/EC (1) because the materials can be separated from one another without the value of their informative content being affected, is every conceivable informative value decisive or only the value which is to be determined on the basis of the purpose of the collection and having regard to the resulting typical conduct of users?

1

---

(1)  Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, OJ 1996 L 77, p. 20.

1

---
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

SKYRA LANCE HARPER, )

)

Appellant, )

)

v. ) Case No. 2D19-2466

)

STATE OF FLORIDA, )

)

Appellee. )

)

Opinion filed September 2, 2020. 

Appeal from the Circuit Court for 

Hillsborough County; Thomas P. Barber, 

Judge.

Howard L. Dimmig, II, Public Defender 

and Susan M. Shanahan, Assistant Public 

Defender, Bartow, for Appellant.

Ashley Moody, Attorney General, 

Tallahassee, and Katherine Coombs Cline, 

Assistant Attorney General, Tampa, for 

Appellee.

PER CURIAM.

Affirmed. 

KHOUZAM, C.J., NORTHCUTT, and KELLY, JJ., Concur.
§ 74.1706 FD&C Yellow No. 6. ( a ) *Identity and specifications.* ( 1 ) The color additive FD&C Yellow No. 6 shall conform in identity and specifications to the requirements of § 74.706(a)(1) and (b).
( 2 ) Color additive mixtures for drug use made with FD&C Yellow No. 6 may contain only those diluents that are suitable and that are listed in part 73 of this chapter as safe for use in color additive mixtures for coloring drugs.
( b ) *Uses and restrictions.* FD&C Yellow No. 6 may be safely used for coloring drugs generally in amounts consistent with current good manufacturing practice.
( c ) *Labeling requirements.* ( 1 ) The label of the color additive and any mixtures intended solely or in part for coloring purposes prepared therefrom shall conform to the requirements of § 70.25 of this chapter.
( 2 ) [Reserved]
( d ) *Certification.* All batches of FD&C Yellow No. 6 shall be certified in accordance with regulations in part 80 of this chapter.
[51 FR 41782, Nov. 19, 1986, as amended at 52 FR 21508, June 8, 1987; 53 FR 49138, Dec. 6, 1988]
I 

118TH CONGRESS 

2D SESSION H. R. 7715 

To authorize additional funding for Food and Drug Administration monitoring 

and prevention of illicit nicotine products at ports of entry, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 19, 2024 

Mr. GALLEGO introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To authorize additional funding for Food and Drug Administration monitoring and prevention of illicit nicotine products at ports of entry, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Vetting and Patrolling 

5 E-Cigarette Imports Act’’ or the ‘‘VAPE Imports Act’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7715 IH

1 SEC. 2. AUTHORIZATION OF APPROPRIATIONS FOR FDA 

2 MONITORING AND PREVENTION OF ILLICIT 

3 NICOTINE PRODUCTS AT PORTS OF ENTRY. 

4 There is authorized to be appropriated $5,000,000 to 

5 the Food and Drug Administration for the purpose of 

6 monitoring and preventing, at ports of entry (including 

7 international mail facilities), illicit nicotine products and 

8 the importation of nicotine products in violation of Federal 

9 law, including by purchasing and maintaining screening 

10 equipment, addressing staffing needs, engaging in part11 nerships with other Federal agencies, and carrying out 

12 such other activities as the Commissioner of Food and 

13 Drugs determines appropriate. The amount authorized to 

14 be appropriated by the preceding sentence is in addition 

15 to any other amounts authorized to be appropriated for 

16 such purpose. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1650 Angiographic injector and syringe. ( a ) *Identification.* An angiographic injector and syringe is a device that consists of a syringe and a high-pressure injector which are used to inject contrast material into the heart, great vessels, and coronary arteries to study the heart and vessels by x-ray photography.
( b ) *Classification.* Class II (special controls). The device, when it is a non-patient contacting balloon inflation syringe intended only to inflate/deflate balloon catheters and monitor pressure within the balloon, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
[45 FR 7907, Feb. 5, 1980, as amended at 84 FR 71811, Dec. 30, 2019]
# C_2014253EN.01006001.xml

| 4.8.2014 | EN | Official Journal of the European Union | C 253/60 |
| --- | --- | --- | --- |

4.8.2014

EN

Official Journal of the European Union

C 253/60

---

Action brought on 9 June 2014 — Neka Novin v Council

(Case T-436/14)

2014/C 253/81

Language of the case: French

Parties

Parties

Applicant: Neka Novin (Yusef Abad, Iran) (represented by: L. Vidal, lawyer)

Applicant:

Defendant: Council of the European Union

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the Council’s decision to maintain the sanction imposed on the applicant as mentioned in the notice of 15 March 2014; |
| --- | --- |

—

annul the Council’s decision to maintain the sanction imposed on the applicant as mentioned in the notice of 15 March 2014;

| — | order the Council to pay the costs. |
| --- | --- |

—

order the Council to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on three pleas in law.

| 1. | First plea, alleging an error of law in so far as the grounds given for maintaining the restrictive measures imposed on the applicant are not sufficient. |
| --- | --- |

1.

First plea, alleging an error of law in so far as the grounds given for maintaining the restrictive measures imposed on the applicant are not sufficient.

| 2. | Second plea, alleging a manifest error of assessment in so far as the defendant wrongly considered that the applicant had acquired specialised equipment that was of direct application in the Iranian nuclear program. |
| --- | --- |

2.

Second plea, alleging a manifest error of assessment in so far as the defendant wrongly considered that the applicant had acquired specialised equipment that was of direct application in the Iranian nuclear program.

| 3. | Third plea, alleging infringement of proportionality and the right to property. |
| --- | --- |

3.

Third plea, alleging infringement of proportionality and the right to property.

---
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1170 Chloride test system. ( a ) *Identification.* A chloride test system is a device intended to measure the level of chloride in plasma, serum, sweat, and urine. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.
( b ) *Classification.* Class II.
<PAGE>   1


              [RYDER SCOTT COMPANY PETROLEUM ENGINEERS LETTERHEAD]


                                                                  
                                                                   EXHIBIT 23(d)


                   CONSENT OF INDEPENDENT PETROLEUM ENGINEERS

     As independent petroleum engineers, we hereby consent to the use of our
name in the Annual Report and Form 10K of Seven Seas Petroleum Inc., for the
period ended December 31, 1997. We further consent to the inclusion of our
estimate of reserves and present value of future net reserves in such Annual
Report.



                                        /s/ RYDER SCOTT COMPANY
                                            PETROLEUM ENGINEERS

                                            RYDER SCOTT COMPANY
                                            PETROLEUM ENGINEERS

Houston, Texas
May 4, 1998
# C_2017424EN.01002801.xml

| 11.12.2017 | EN | Official Journal of the European Union | C 424/28 |
| --- | --- | --- | --- |

11.12.2017

EN

Official Journal of the European Union

C 424/28

---

Judgment of the General Court of 26 October 2017 — Marine Harvest v Commission

(Case T-704/14) (1)

1

((Competition - Concentrations - Decision imposing a fine for putting into effect a concentration prior to its notification and authorisation - Article 4(1), Article 7(1) and (2) and Article 14 of Regulation (EC) No 139/2004 - Negligence - Principle ne bis in idem - Gravity of the infringement - Amount of the fine))

(2017/C 424/39)

Language of the case: English

Parties

Parties

Applicant: Marine Harvest ASA (Bergen, Norway) (represented by: R. Subiotto QC)

Applicant:

Defendant: European Commission (represented by: M. Farley, C. Giolito and F. Jimeno Fernández, acting as Agents)

Defendant:

Re:

Re:

Application based on Article 263 TFEU and seeking, principally, annulment of Commission Decision C(2014) 5089 final of 23 July 2014 imposing a fine for putting into effect a concentration in breach of Article 4(1) and Article 7(1) of Regulation (EC) No 139/2004 (Case COMP/M.7184 — Marine Harvest/Morpol), and, in the alternative, annulment or reduction of the fine imposed on the applicant.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Marine Harvest ASA to pay the costs. |
| --- | --- |

2.

Orders Marine Harvest ASA to pay the costs.

---

(1)  OJ C 409, 17.11.2014.

1

---
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4773]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances Notice of Registration

    By Notice dated November 23, 2009, and published in the Federal 
Register on December 2, 2009 (74 FR 63155), Cambrex Charles City, Inc., 
1205 11th Street, Charles City, Iowa 50616, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the basic classes of controlled 
substances for manufacture of active pharmaceutical ingredients for 
sale to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Cambrex Charles City, Inc. to import the basic classes 
of controlled substances is consistent with the public interest, and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Cambrex Charles City, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

     Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4773 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P